A Comparison of Methodologies for the Study of Functional Transmitter Neurochemistry in Human Brain

Journal of Neurochemistry

Volumn 50, Issue 5, 1988, Pages 1333-1345

  Dodd, Peter R ^a   Hambley, John W ^a,b   Cowburn, Richard F ^c   Hardy, John A ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NS W Institute of Technology ^*  (Australia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Animal models; Human brain; Neurotransmitter function; Peripheral tissue models; Postmortem

Indexed keywords

BRAIN; HUMAN CELL; METHODOLOGY; NEUROCHEMISTRY; PRIORITY JOURNAL; SHORT SURVEY;

ANIMAL; BRAIN; COMPARATIVE STUDY; HUMAN; MODELS, BIOLOGICAL; NEUROCHEMISTRY; NEUROTRANSMITTERS; PERIPHERAL NERVES; POSTMORTEM CHANGES; SUPPORT, NON-U.S. GOV'T;

EID: 0023874850     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1988.tb03013.x     Document Type: Review

References (102)

1. Can animal models really predict anxiety
2. The human platelet as a pharmacologic model for the adrenergic neuron
3. Towards animal models of mental retardation
4. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
5. The uptake of tyramine by rat platelets
6. Uptake of labelled amino acids in human erythrocytes in vitro
7. Acetylcholine synthesis and glucose oxidation are preserved in human brain obtained shortly after death
8. Repeated administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine to rats is not toxic to striatal dopamine neurones
9. Carbohydrate and energy metabolism
10. Biochemistry and basic mechanisms in epilepsy
11. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients
12. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
13. Carbachol‐stimulated phosphatidyl inositol hydrolysis in the cerebral cortex after freezing and post mortem delay. [Abstract]
14. Neurochemical and behavioural effects of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) in rat, guinea pig and monkey
15. Human blood platelet monoamine oxidase
16. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem
17. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain
18. A comparison of high affinity synaptosomal uptake of D‐aspartate in rat and human brain
19. Clinical, neuropathological and pharmacological aspects of Huntington's disease: correlates with a new animal model
20. The turnover of 5‐hydroxytryptamine
21. 3H‐yohimbine affinity
22. No evidence for the preservation of somatostatin‐containing neurons after intrastriatal injections of quinolinic acid
23. Release of amino acids from the maturing cobalt‐induced epileptic focus
24. Metabolic and secretory processes in nerve‐endings isolated from post‐mortem brain
25. Release of amino acids from chronic epileptic and sub‐epileptic foci in vivo
26. Adenosine receptors in post‐mortem human cerebral cortex and the effect of carbamazepine
27. Optimization of freezing, storage and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain
28. Heterogeneous distribution of benzodiazepine receptors in the human striatum: a quantitative autoradiographic study comparing the pattern of receptor labelling with the distribution of acetylcholinesterase staining
29. Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum
30. Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease
31. The pros and cons of using human brain autopsy samples for radioligand binding experiments
32. Uptake of catecholamines by human synaptosomes
33. Neuropeptides in the basal ganglia
34. Protection of neocortical tissue prisms from freeze‐thaw injury by dimethyl sulphoxide
35. Studies in postmortem dopamine uptake. (I). Kinetic characterisation of the synaptosomal dopamine uptake in rat and human brain after postmortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake
36. Studies in postmortem dopamine uptake. (II). Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia
37. Uptake of gamma‐aminobutyric acid by human blood platelets: comparison with CNS uptake
38. Metabolic and functional studies on post‐mortem human brain
39. Use of post‐mortem human synaptosomes for studies of metabolism and transmitter amino acid release
40. Metabolically active synaptosomes can be prepared from frozen rat and human brain
41. Amino acid transport by synaptosomes isolated from post mortem human brain
42. The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue
43. Uptake of γ‐aminobutyric acid and glycine by synaptosomes from postmortem human brain
44. Region‐specific loss of glutamate innervation in Alzheimer's disease
45. A disorder of cortical GABAergic innervation in Alzheimer's disease
46. The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brain
47. Pathological changes in alcoholic brain shrinkage
48. Are we drinking our neurones away
49. Human retinas synthesize and release acetylcholine
50. Autoradiographic localization of calcitonin gene‐related peptide binding sites in human and rat brains
51. Drug‐induced behavioural models of central disorders
52. Analysis of CSF amine metabolites and precursors including tryptophan, 5HIAA and HVA by HPLC using fluorescence and electrochemical detection in primates: effect of probenecid
53. Neuropeptide Y. somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and histochemical study
54. Brain GABA binding is normal in rats with thioacetamide‐induced hepatic encephalopathy despite elevated plasma GABA‐like activity
55. Plasma GABA, GABA‐like activity and the brain GABA‐benzodiazepine receptor complex in rats with chronic hepatic encephalopathy
56. Plasma GABA concentrations and cerebro‐cortical GABA receptor binding and function in dogs with congenital portosystemic encephalopathy
57. The human platelet as a model for the glutamatergic neuron: platelet uptake of l‐glutamate
58. Platelet glutamate uptake and aspartate uptake in Huntington's disease
59. Blood platelets contain a neuron‐specific enolase
60. +)‐ATPase activity in Down's syndrome platelets
61. Duplication of biochemical changes of Huntington's chorea by intrastriatal injection of glutamic and kainic acids
62. Benzodiazepine receptors on human blood platelets
63. 3H‐acetylcholine efflux from Alzheimer brain slices to normal level
64. Binding of benzodiazepines to blood platelets from various species
65. Intra‐ and extrasynaptosomal deamination of dopamine and noradrenaline by the two forms of human brain monoamine oxidase. Implications for the neurotoxicity of N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in man
66. Platelet uptake of serotonin and dopamine in Huntington disease
67. GABAergic mechanisms in blood cells: their possible role
68. 3H]‐LSD binding sites in the raphe nuclei of the brainstem
69. β‐Adrenoceptor subtypes in the human brain: autoradiographic localization
70. The diffuse neuroendocrine system and the APUD concept: related ‘endocrine’ peptides in brain, intestine, pituitary, placenta, and anuran cutaneous glands
71. Platelets as models for monoaminergic neurons
72. 3H]strychnine
73. Glutamate denervation in Alzheimer's disease: a cautionary note
74. Excessive cellular acidosis: an important mechanism of neuronal damage in the brain
75. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease
76. Glutamate and Huntington's disease
77. 3H]Ro5‐4864 benzodiazepine binding in the kainatelesioned striatum and Huntington's diseased basal ganglia
78. Effect of tissue storage and freezing on brain glutamate uptake
79. Post‐mortem high affinity glutamate uptake in human brain
80. The turnover of catecholamines
81. Cell damage in the brain: a speculative synthesis
82. Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease
83. The evoked release of endogenous amino acids from tissue prisms of human‐neocortex
84. Blood platelets as a model for monoamine‐containing neurons
85. The human platelet. A diagnostic tool for the study of biogenic amines in psychiatric and neurological disorders
86. Platelets as pharmacologic models for the receptors and biochemistry of monoaminergic neurons
87. A kinetic and pharmacologic analysis of 5‐hydroxytryptamine transport by human platelets and platelet storage granules: comparisons with central serotonergic neurons
88. The uptake of serotonin and dopamine by homogenates of frozen rat and human brain
89. Interactions of monoamine oxidase and MPTP in human brain
90. 3H]UK‐14,304, in depressed patients and matched controls
91. The activities of butyrylcho‐linesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale
92. 3H]‐diazepam binding sites on rat blood platelets
93. Topical convulsant metals
94. Effect of post‐mortem storage on synaptic 5‐HT binding and uptake in mammalian brain
95. 4‐Aminobutyrate:2‐oxoglutarate aminotransferase in blood platelets
96. Nicotinic acetylcholine binding sites in Alzheimer's disease
97. The validity of animal models of depression
98. Human brain mono‐amineoxidase: multiple forms and selective inhibitors
99. Autoradiographic localization of benzodiazepine receptors in the brains of humans and animals